2QU3
BACE1 with Compound 2
Summary for 2QU3
| Entry DOI | 10.2210/pdb2qu3/pdb |
| Related | 2QU2 |
| Descriptor | Beta-secretase 1, N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide (3 entities in total) |
| Functional Keywords | bace1, acylguanidine, inhibitor, alternative splicing, aspartyl protease, glycoprotein, hydrolase, membrane, protease, transmembrane, zymogen |
| Biological source | Homo sapiens (Human) |
| Cellular location | Membrane; Single-pass type I membrane protein: P56817 |
| Total number of polymer chains | 1 |
| Total formula weight | 46868.93 |
| Authors | Chopra, R. (deposition date: 2007-08-03, release date: 2008-08-05, Last modification date: 2024-10-30) |
| Primary citation | Fobare, W.F.,Solvibile, W.R.,Robichaud, A.J.,Malamas, M.S.,Manas, E.,Turner, J.,Hu, Y.,Wagner, E.,Chopra, R.,Cowling, R.,Jin, G.,Bard, J. Thiophene substituted acylguanidines as BACE1 inhibitors. Bioorg.Med.Chem.Lett., 17:5353-5356, 2007 Cited by PubMed Abstract: A series of thiophene-substituted acylguanidines were designed from a pyrrole substituted acylguanidine HTS lead. This template allowed a greater flexibility, through differential Suzuki couplings, to explore the binding site of BACE1 and to enhance the inhibitory potencies. This exploration provided a 25-fold enhancement in potency to yield compound 10a, which was 150 nM in a BACE1 FRET assay. PubMed: 17761418DOI: 10.1016/j.bmcl.2007.08.010 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report






